NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue:
Pharmaceutical Contract Manufacturing - Global Market Trends
Advertisement
http://www.reportlinker.com/p0164248/Pharmaceutical-Contract-Manufacturing---Global-Market-Trends.html
Global pharma industry faces numerous challenges in the form of increasing competition in generic markets, rising cost of new product development, declining research and development (R&D) productivity, shrinking average patent life, and mounting governmental pressure to reduce drug prices. Given the backdrop of such a competitive landscape, the decisive factors for growth and sustainability are faster new drug development and cost containment with Pharmaceutical Contract Manufacturing emerging as a strategic option offering several advantages. Firstly, outsourcing provides pharma companies the opportunity to avail flexibility, quicker time to market, and lower scale-up costs. Thus, companies will be able to meet growing demand for new drugs and focus on their core competencies. Secondly, outsourcing enables companies to reduce excess capacity in their manufacturing networks and restructure supply chains. Finally, value-added outsourcing services meet the increased demand for specialized manufacturing capabilities in key technical niches (such as lyophilization) and increased demand for back-up sources of supply.
Advertisement
These and other market data and trends are presented in "Pharmaceutical Contract Manufacturing: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
PHARMACEUTICAL CONTRACT MANUFACTURING BMR-1048
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. MARKET DYNAMICS 4
An Insight into the Rise of PCM 4
Industry Potential 4
3. SERVICE OVERVIEW 5
Introduction 5
Injectables (injections, vials, and IV solutions) 5
Solid Dosage Forms (SDFs) (Tablets and Capsules) 5
Liquid Dosage Forms (LDFs) (Syrups and Suspensions) 6
A Focus on Bio-Manufacturing 6
4. TRENDS AND ISSUES 7
Outsourcing Emerges as a Strategic Priority for Pharmaceutical
Companies 7
Asia Dominates Regional Growth, North America Retains Position
as Largest Market 8
Virtual Pharma vs. Blockbuster Model 8
Investment Risks in Pharmaceutical Contract 9
Quality Assurance Risk 9
Drug Development Risk 9
Acquisition Risk 9
Client Dependency Risk 9
5. CORPORATE DEVELOPMENTS 9
Jubilant Acquires Draxis for US$ 253 Million 9
JHP Acquires Assets of King Pharmaceuticals 10
NextPharma Acquires Bioserv Corporation 10
Dr. Reddy's to Acquire Dowpharma's Facilities 10
PharmAthene to Acquire Avecia's Biodefense Vaccine Operations 11
Bioserv Enters into an Outsourcing Agreement with BioLife
Solutions 12
Eden Biodesign and Stealthyx Therapeutics Ink an Agreement 12
NPIL Pharma to Expand HPS Sites in Scotland 12
Dishman Pharma Installs New API Facilities 13
Patheon Divests Niagara-Burlington Manufacturing Business to
Pharmetics 13
Jubilant Organosys Acquires Hollister-Stier Laboratories 13
Hikma Pharmaceuticals Acquires Thymoorgan GmbH Pharmazie 14
Meda Acquires Recip 14
Keata Pharma to Acquire Pfizer's Production Facility in Canada 15
STADA Acquires MAKIZ 15
Nextpharma to Expand its Cytostatics Production Facility 16
Haupt Pharma Establishes Production Facility in Malta 16
6. MAJOR PLAYERS 17
Althea Technologies (USA) 17
Catalent Pharma Solutions (USA) 17
Dishman Pharmaceuticals and Chemicals Ltd (India) 17
HAUPT Pharma AG (Germany) 18
Jubilant Organosys Ltd (India) 18
Kemwell Pvt. Ltd (India) 18
NextPharma (UK) 18
Nipro Corp (Japan) 18
Patheon, Inc. (Canada) 19
Penn Pharmaceutical Services Ltd (UK) 19
Royal DSM N.V. (Netherlands) 19
7. MARKET ANALYTICS 20
8. THE UNITED STATES 24
Trends 24
Pharma Companies Increasingly Outsource Manufacturing Activity 24
Injectables Segment Witnesses Upward Growth Trend 24
Competitive Landscape 24
9. CANADA 26
10. JAPAN 27
Impact of Contract Manufacturing on Japanese Pharmaceutical
Sector 27
11. EUROPE 28
Trend 28
Injectables Segment Offers Promising Potential 28
Competitive Scenario 28
12. ASIA-PACIFIC 30
Trends 30
Upbeat Market for Pharmaceutical Contract Manufacturing 30
Competitive Scenario 30
India 30
13. REST OF WORLD 32
EXHIBITS
Table 1: Global Markets for Pharmaceutical Contract
Manufacturing by Region for the Period 2007-2015 (Sales in US$
Million)
Table 2: Percentage Breakdown of Global Markets for
Pharmaceutical Contract Manufacturing by Region for the Years
2008 & 2012
Table 3: Global Markets for Pharmaceutical Contract
Manufacturing of Injectables by Region for the Period
2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Markets for
Pharmaceutical Contract Manufacturing of Injectables by
Region for the Years 2008 & 2012
Table 5: Global Markets for Pharmaceutical Contract
Manufacturing of Solid Dosage Forms by Region for the Period
2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Markets for
Pharmaceutical Contract Manufacturing of Solid Dosage Forms by
Region for the Years 2008 & 2012
Table 7: Global Markets for Pharmaceutical Contract
Manufacturing of Liquid Dosage Forms by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Markets for
Pharmaceutical Contract Manufacturing of Liquid Dosage Forms
by Region for the Years 2008 & 2012
Table 9: Pharmaceutical Contract Manufacturing Market by
Product Segment in the US: 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in the US for the
Years 2008 & 2012
Table 11: Pharmaceutical Contract Manufacturing Market by
Product Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 12: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in Canada for the
Years 2008 & 2012
Table 13: Pharmaceutical Contract Manufacturing Market by
Product Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in Japan for the Years
2008 & 2012
Table 15: Pharmaceutical Contract Manufacturing Market by
Product Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 16: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in Europe for the
Years 2008 & 2012
Table 17: Pharmaceutical Contract Manufacturing Market by
Product Segment in Asia-Pacific: 2007-2015 (Sales in US$
Million)
Table 18: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in Asia-Pacific for
the Years 2008 & 2012
Table 19: Pharmaceutical Contract Manufacturing Market by
Product Segment in Rest of World: 2007-2015 (Sales in US$
Million)
Table 20: Percentage Breakdown of Pharmaceutical Contract
Manufacturing Market by Product Segment in Rest of World for
the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Medical Equipment and Supply Industry: Pharmaceutical Contract Manufacturing - Global Market Trends
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker